Yes: The immunogenic proteins characterizing a number of major cancers have been defined. They have been sequenced and the functional monoclonals targeting the advanced forms of disease are in clinical trails. The vaccines for high risk patients are being developed and when given with chemo, a possible radiolabelled mAb and immunostimulant may change the entire picture of clinical cancer.
Answered 2/8/2015
3.2k views
13 doctors weighed in across 4 answers
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
9 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question